Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Human Papillomavirus Infection: early-phase trial registry
4 of 23 indexed Human Papillomavirus Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #724 of 28,707 conditions by registered trial count.
23 US clinical trials · 4 currently recruiting · #724 of 28,707 conditions by registered trial count
Human Papillomavirus Infection: 23 US clinical trials tracked, 4 recruiting.
Human Papillomavirus Infection is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 6 of these trials.
Enrollment posture brief
Registry condition human-papillomavirus-infection
OPEN 4 | RECR 17% | LATE 2 | EARLY 5 | RANK #724 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Arthritis, Rheumatoid (17% recruiting · 29 trials)
Human Papillomavirus Infection lists 4 open slots (17% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Human Papillomavirus Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Human Papillomavirus Infection is recruiting below its size-band peers.
4 of 23 indexed trials (17.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Human Papillomavirus Infection research.
National Cancer Institute (NCI) accounts for 6 of 23 trials (26.1%). 15 distinct sponsors appear on at least one study for this condition label.
-
Typical Human Papillomavirus Infection enrolment sits around 500 participants.
Median target enrolment is 500 among the 23 trials that report a genuine target (sentinel values excluded). 5 of those (21.7%) plan for fewer than 100 participants.
-
Human Papillomavirus Infection research is mostly interventional.
21 interventional and 2 observational studies make up this index (91.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
23 total, page 1 of 1
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
The University of Texas Health Science Center, Houston
NCT06598475
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
National Cancer Institute (NCI)
NCT06498661
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
National Cancer Institute (NCI)
NCT07281430
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
University of Virginia
NCT05860725
Throat and Other HPV-Related Cancers in Men: Identifying Them Early
Baylor College of Medicine
NCT02897427
Promoting HPV Vaccination Among Young Adults in Texas
M.D. Anderson Cancer Center
NCT05057312
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
GOG Foundation
NCT00892866
The Parents in Appalachia Receive Education Needed for Teen Project
Ohio State University Comprehensive Cancer Center
NCT01901770
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
ECOG-ACRIN Cancer Research Group
NCT01898494
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
National Cancer Institute (NCI)
NCT06611553
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
National Cancer Institute (NCI)
NCT06611540
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Jonsson Comprehensive Cancer Center
NCT02816879
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Roswell Park Cancer Institute
NCT06256718
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
Baylor College of Medicine
NCT06577220
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
NCT03036930
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
NCT00973362
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
AIDS Malignancy Consortium
NCT02135419
Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
M.D. Anderson Cancer Center
NCT00508170
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
University of Pittsburgh
NCT00572832
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
NCT00303823
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Mayo Clinic
NCT01932697
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
Jonsson Comprehensive Cancer Center
NCT02048020
Video-Assisted Counseling for HPV Vaccination
Le Bonheur Children's Hospital
NCT03510091
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 5 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Human Papillomavirus Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Human Papillomavirus Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Human Papillomavirus Infection page
23 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Human Papillomavirus Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Human Papillomavirus Infection trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Human Papillomavirus Infection condition card totals 23 registered trials; most-linked intervention Biospecimen Collection; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.